Similar to ischemic stroke, plasma concentrations of GFAP concentration at baseline were significantly associated with poor outcomes after subarachnoid hemorrhage, as observed by Zheng et al. (2017) at 6 months after the symptom onset (Zheng et al., 2017). This evidence concerns the gene GFAP and ischemic stroke.